
GlaxoSmithKline plc GSK
$ 54.54
-1.31%
Annual report 2024
added 02-28-2026
GlaxoSmithKline plc Operating Cycle 2011-2026 | GSK
Annual Operating Cycle GlaxoSmithKline plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 0.02 | 0.04 | 0.04 | 0.08 | 0.06 | 200 | 194 | 211 | 166 | 184 | 193 |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 211 | 0.02 | 104 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
173 | $ 3.44 | -4.32 % | $ 1.03 B | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.79 | -1.15 % | $ 4.31 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
ADMA Biologics
ADMA
|
391 | $ 15.36 | -2.17 % | $ 3.66 B | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Apellis Pharmaceuticals
APLS
|
115 | $ 20.28 | 0.65 % | $ 2.56 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Anika Therapeutics
ANIK
|
325 | $ 14.05 | -1.44 % | $ 206 M | ||
|
ANI Pharmaceuticals
ANIP
|
295 | $ 74.36 | -1.64 % | $ 1.44 B | ||
|
AVEO Pharmaceuticals
AVEO
|
111 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
273 | $ 162.43 | 0.6 % | $ 8.08 B | ||
|
BioCryst Pharmaceuticals
BCRX
|
947 | $ 8.49 | -0.18 % | $ 1.75 B | ||
|
BridgeBio Pharma
BBIO
|
285 | $ 65.66 | -0.78 % | $ 12.6 B | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
BioDelivery Sciences International
BDSI
|
436 | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
349 | - | -7.31 % | $ 87 M | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
BioMarin Pharmaceutical
BMRN
|
733 | $ 61.3 | 1.21 % | $ 11.8 B | ||
|
Codexis
CDXS
|
50.2 | $ 1.23 | -2.38 % | $ 90.3 M | ||
|
Clovis Oncology
CLVS
|
65.5 | - | -7.23 % | $ 13 M |